Mengxi Zhou

575 total citations
26 papers, 434 citations indexed

About

Mengxi Zhou is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Mengxi Zhou has authored 26 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Mengxi Zhou's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Prostate Cancer Treatment and Research (5 papers) and Thyroid Disorders and Treatments (3 papers). Mengxi Zhou is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Prostate Cancer Treatment and Research (5 papers) and Thyroid Disorders and Treatments (3 papers). Mengxi Zhou collaborates with scholars based in China, United States and France. Mengxi Zhou's co-authors include Jinghong Li, Ruijie Deng, Xucong Teng, Xiaojun Ren, Yupeng Sun, Xin Tang, Feng Zhang, Li Zhao, Xinxin Chen and Tito Fojo and has published in prestigious journals such as Analytical Chemistry, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Mengxi Zhou

24 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mengxi Zhou China	10	221	101	56	55	46	26	434
Laixing Wang China	14	177 0.8×	125 1.2×	54 1.0×	57 1.0×	167 3.6×	34	506
Julia E. Neumann Germany	13	131 0.6×	46 0.5×	51 0.9×	25 0.5×	86 1.9×	37	388
Chunhong Qin China	12	205 0.9×	77 0.8×	22 0.4×	16 0.3×	31 0.7×	19	459
Katrina Moore Australia	9	148 0.7×	83 0.8×	25 0.4×	18 0.3×	35 0.8×	18	397
René Johannes Laursen Denmark	7	95 0.4×	75 0.7×	83 1.5×	28 0.5×	33 0.7×	15	385
Edward J. Estlin United Kingdom	8	97 0.4×	69 0.7×	71 1.3×	14 0.3×	75 1.6×	10	380
Felix Mircea Brehar Romania	9	100 0.5×	46 0.5×	16 0.3×	18 0.3×	61 1.3×	40	260
Francesca Amoroso Italy	9	212 1.0×	41 0.4×	32 0.6×	18 0.3×	26 0.6×	13	586
Quanjun Deng China	10	191 0.9×	111 1.1×	57 1.0×	11 0.2×	38 0.8×	19	330
Claudia D’Agostino Belgium	6	217 1.0×	73 0.7×	22 0.4×	21 0.4×	15 0.3×	7	324

Countries citing papers authored by Mengxi Zhou

Since Specialization

Citations

This map shows the geographic impact of Mengxi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengxi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengxi Zhou more than expected).

Fields of papers citing papers by Mengxi Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengxi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengxi Zhou. The network helps show where Mengxi Zhou may publish in the future.

Co-authorship network of co-authors of Mengxi Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Mengxi Zhou. A scholar is included among the top collaborators of Mengxi Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengxi Zhou. Mengxi Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leuva, Harshraj, Mengxi Zhou, Benjamin A. Teply, et al.. (2025). Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer. JAMA Network Open. 8(11). e2540730–e2540730.

Zhou, Mengxi, Edward P. Gelmann, Lyndon Luk, et al.. (2024). Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors. The Oncologist. 29(9). 817–e1213. 5 indexed citations

Leuva, Harshraj, Mengxi Zhou, Izak Faiena, et al.. (2024). Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent -rate method ideal for real-world analyses. EBioMedicine. 107. 105288–105288. 2 indexed citations

Zhou, Mengxi, Yajing Chen, Li Wu, et al.. (2024). Vestibular-evoked myogenic potential abnormalities in Parkinson’s disease with freezing of gait. Journal of Neurology. 271(6). 3527–3536. 4 indexed citations

Leuva, Harshraj, George W. Moran, Mengxi Zhou, et al.. (2024). Assessment of PSA responses and changes in the rate of tumor growth -rate with immune checkpoint inhibitors in US Veterans with prostate cancer. Seminars in Oncology. 51(3-4). 59–68. 2 indexed citations

Zhou, Mengxi, et al.. (2023). TMEM147 is a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. Genetics and Molecular Biology. 46(2). e20220323–e20220323. 5 indexed citations

Zhou, Mengxi, et al.. (2023). Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials. Breast Cancer Research and Treatment. 204(1). 39–47.

Leuva, Harshraj, Mengxi Zhou, Norbert Bräu, et al.. (2022). Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans. Seminars in Oncology. 49(5). 363–370. 7 indexed citations

Wu, Li, Qian Xu, Mengxi Zhou, et al.. (2022). Plasma miR-153 and miR-223 Levels as Potential Biomarkers in Parkinson’s Disease. Frontiers in Neuroscience. 16. 865139–865139. 15 indexed citations

10.

Chen, Yajing, Qian Xu, Li Wu, et al.. (2022). REM sleep behavior disorder correlates with constipation in de novo Chinese Parkinson’s disease patients. Neurological Sciences. 44(1). 191–197. 7 indexed citations

11.

Zhou, Mengxi, Qin Wang, Qian Xu, et al.. (2022). Oculomotor impairments in de novo Parkinson’s disease. Frontiers in Aging Neuroscience. 14. 985679–985679. 14 indexed citations

12.

Zhou, Yulin, Mengxi Zhou, Yicheng Qi, et al.. (2021). The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves’ disease. Therapeutic Advances in Endocrinology and Metabolism. 12. 2425414223–2425414223. 8 indexed citations

13.

Chen, Xinxin, Yanqiu Wang, Yicheng Qi, et al.. (2021). Expansion of inflammatory monocytes in periphery and infiltrated into thyroid tissue in Graves’ disease. Scientific Reports. 11(1). 13443–13443. 7 indexed citations

14.

Blagoev, Krastan B., et al.. (2021). Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer. Oncotarget. 12(1). 15–21. 4 indexed citations

15.

Maitland, Michael L., Julia Wilkerson, Binsheng Zhao, et al.. (2020). Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate Evaluation. Clinical Cancer Research. 26(24). 6464–6474. 26 indexed citations

16.

Zhou, Mengxi, et al.. (2020). Distribution of cancer genes in human chromosomes. Seminars in Oncology. 47(6). 409–413. 4 indexed citations

17.

Leuva, Harshraj, Keith Sigel, Mengxi Zhou, et al.. (2019). A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide. Seminars in Oncology. 46(4-5). 351–361. 17 indexed citations

18.

Zhou, Mengxi, Liyun Shen, Jiao Qin, et al.. (2019). Role of Magnetic Resonance Imaging in the Assessment of Active Thyroid-Associated Ophthalmopathy Patients with Long Disease Duration. Endocrine Practice. 25(12). 1268–1278. 13 indexed citations

19.

Zhou, Mengxi, et al.. (2019). Cascade Transcription Amplification of RNA Aptamer for Ultrasensitive MicroRNA Detection. Analytical Chemistry. 91(8). 5295–5302. 94 indexed citations

20.

Chen, Xinxin, Fengjiao Huang, Yicheng Qi, et al.. (2018). Serum and thyroid tissue level of let-7b and their correlation with TRAb in Graves’ disease. Journal of Translational Medicine. 16(1). 188–188. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact